Effects of storage temperature on hematopoietic stability and microbial safety of BM aspirates

Bone Marrow Transplantation

Volumn 49, Issue 3, 2014, Pages 338-348

  Hahn, S ^a   Sireis, W ^a   Hourfar, K ^a   Karpova, D ^a   Dauber, K ^a   Kempf, V A J ^a   Seifried, E ^a   Schmidt, M ^a   Bonig, H ^a,b,c  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF WASHINGTON   (United States)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

bacteria; bioburden; contamination; quality; safety

Indexed keywords

ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIUM CONTAMINATION; BONE MARROW; COLD; ESCHERICHIA COLI; GROWTH INHIBITION; HEMATOLOGICAL PARAMETERS; HEMATOPOIETIC QUALITY; HUMAN; HUMAN TISSUE; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; SAFETY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STORAGE TEMPERATURE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LABORATORY DIAGNOSIS; MICROBIOLOGY; PATHOLOGY; PROCEDURES; SKIN; STEM CELL; TEMPERATURE; TIME; TISSUE PRESERVATION;

ANTIINFECTIVE AGENT;

ANTI-BACTERIAL AGENTS; BONE MARROW; ESCHERICHIA COLI; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KLEBSIELLA PNEUMONIAE; PROPIONIBACTERIUM ACNES; SKIN; SPECIMEN HANDLING; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STEM CELLS; TEMPERATURE; TIME FACTORS; TISSUE PRESERVATION;

EID: 84904242149     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2013.176     Document Type: Article

References (66)

1. NMDP. Trends in allogeneic transplants 2010, Available from: http://marrow.org/Physicians/Unrelated-Search-and-Transplant/ Trends-in-Allo-Transplants.aspx#refs (accessed 9 June 2013).
2. Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A, Niederwieser D. Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors. Bone Marrow Transplant 2007; 39: 71-87.
3. van Rood JJ, Oudshoorn M. Eleven million donors in Bone Marrow Donors Worldwide! Time for reassessment? Bone Marrow Transplant 2008; 41: 1-9.
4. Blaise D, Kuentz M, Fortanier C, Bourhis JH, Milpied N, Sutton L et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle. J Clin Oncol 2000; 18: 537-546.
5. Schmitz N, Beksac M, Hasenclever D, Bacigalupo A, Ruutu T, Nagler A et al. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. Blood 2002; 100: 761-767.
6. Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood 2000; 95: 3702-3709.
7. Thomas ED, Storb R. Technique for human marrow grafting. Blood 1970; 36: 507-515.
8. Jacobs MR, Good CE, Fox RM, Roman KP, Lazarus HM. Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine. Transfusion (e-pub ahead of print 5 March 2013; doi:10.1111/trf.12150).
9. Lowder JN, Whelton P. Microbial contamination of cellular products for hema-tolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact. Cytotherapy 2003; 5: 377-390.
10. Prince HM, Page SR, Keating A, Saragosa RF, Vukovic NM, Imrie KR et al. Microbial contamination of harvested bone marrow and peripheral blood. Bone Marrow Transplant 1995; 15: 87-91.
11. Padley D, Koontz F, Trigg ME, Gingrich R, Strauss RG. Bacterial contamination rates following processing of bone marrow and peripheral blood progenitor cell preparations. Transfusion 1996; 36: 53-56.
12. Kamble R, Pant S, Selby GB, Kharfan-Dabaja MA, Sethi S, Kratochvil K et al. Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts. Transfusion 2005; 45: 874-878.
13. Panterne B. Ten Years of External Quality Control for Cellular Therapy Products in France Progress in Molecular and Environmental Bioengineering-From Analysis and Modeling to Technology Applications. InTech 2011, Available from: URL: http://www.intechopen.com/books/progress-in-molecular-and-environmental- bio-engineering-from-analysis-and-modeling-to-technology-applications/ ten-years-of-external-quality-control-for-cellular-therapy-products-in-france. (last accessed 9-06-2013).
14. Vanneaux V, Föis E, Robin M, Rea D, Latour RPde, Biscay N et al. Microbial contamination of BM products before and after processing: a report of incidence and immediate adverse events in 257 grafts. Cytotherapy 2007; 9: 508-513.
15. Jestice HK, Farrington M, Hunt C, Matthews I, Scott MA, Foreman J et al. Bacterial contamination of peripheral blood progenitor cells for transplantation. Transfus Med 1996; 6: 103-110.
16. Rowley SD, Davis J, Dick J, Braine HG, Charache P, Saral R et al. Bacterial contamination of bone marrow grafts intended for autologous and allogeneic bone marrow transplantation. Incidence and clinical significance. Transfusion 1988; 28: 109-112.
17. Lazarus HM, Magalhaes-Silverman M, Fox RM, Creger RJ, Jacobs M. Contamination during in vitro processing of bone marrow for transplantation: clinical significance. Bone Marrow Transplant 1991; 7: 241-246.
18. Webb IJ, Coral FS, Andersen JW, Elias AD, Finberg RW, Nadler LM et al. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering. Transfusion 1996; 36: 782-788.
19. Schwella N, Zimmermann R, Heuft HG, Blasczyk R, Beyer J, Rick O et al. Micro-biologic contamination of peripheral blood stem cell autografts. Vox Sang 1994; 67: 32-35.
20. Goldman JM. A special report: bone marrow transplants using volunteer donors-recommendations and requirements for a standardized practice throughout the world-1994 update. The WMDA Executive Committee. Blood 1994; 84: 2833-2839.
21. Petersen FB, Weinberg P, Hansen JA, Thomas ED. Collection and transportation of human bone marrow cells from unrelated donors. Transfus Sci 1991; 12: 155-159.
22. Miller JP. Issues in Transportation of URD PBSC and Marrow Products. Available from: URL:http://www.celltherapysociety.org/files/PDF/Meetings/ISCT- 2009/Pre-sentations/Wednesday/Grande-BallroomA/Wed-0900-1-Miller-Ball-A.pdf. (last accessed 9-06-2013).
23. Bone Marrow Transplant Clinical Trials Network. A Phase III Randomized, Multi-center Trial Comparting G-CSF Mobilized Peripheral Blood Stem Cell with Marrow Transplantation from HLA Compatible Unrelated Donors. BMT CTN Protocol 0201, Version 8.0. Available from: https://web.emmes.com/study/bmt2/protocol/ 0201-protocol/0201-PB-v-BM-Protocol-v8.0.pdf (last accessed 9-06-2013).
24. Zentrales Knochenmarkspender-Register Deutschland (ZKRD). Deutsche Standards für die nicht verwandte Blutstammzellspende [German standards for unrelated stem cell donations]-Version 8; 2012.
25. Cleaver SA, Warren P, Kern M, Hurley CK, Raffoux C, Keller J et al. Donor work-up and transport of bone marrow-recommendations and requirements for a standardized practice throughout the world from the Donor Registries and Quality Assurance Working Groups of the World Marrow Donor Association (WMDA). Bone Marrow Transplant 1997; 20: 621-629.
26. Dauber K, Becker D, Odendahl M, Seifried E, Bonig H, Tonn T et al. Enumeration of viable CD34(+) cells by flow cytometry in blood, bone marrow and cord blood: results of a study of the novel BD stem cell enumeration kit. Cytotherapy 2011; 13: 449-458.
27. Bonig H, Priestley GV, Oehler V, Papayannopoulou T. Hematopoietic progenitor cells (HPC) from mobilized peripheral blood display enhanced migration and marrow homing compared to steady-state bone marrow HPC. Exp Hematol 2007; 35: 326-334.
28. Thorpe TC, Wilson ML, Turner JE, DiGuiseppi JL, Willert M, Mirrett S et al. BacT/Alert: an automated colorimetric microbial detection system. J Clin Microbiol 1990; 28: 1608-1612.
29. Dreier J, Vollmer T, Kleesiek K. Novel flow cytometry-based screening for bacterial contamination of donor platelet preparations compared with other rapid screening methods. Clin Chem 2009; 55: 1492-1502.
30. Sireis W, Rüster B, Daiss C, Hourfar MK, Capalbo G, Pfeiffer H et al. Extension of platelet shelf life from 4 to 5 days by implementation of a new screening strategy in Germany. Vox Sang 2011; 101: 191-199.
31. Sireis W, Hourfar MK, Seifried E, Schmidt M. How to improve blood safety with respect to bacterial contaminations? Vox Sang 2012; 103: 87-88.
32. Foeken LM, Green A, Hurley CK, Marry E, Wiegand T, Oudshoorn M. Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports. Bone Marrow Transplant 2010; 45: 811-818.
33. NMDP. (ed). NMDP Standards. 20th ed. (National Marrow Donor Program: St.: Paul, MN, 2009.
34. Lazarus HM, Kan F, Tarima S, Champlin RE, Confer DL, Frey N et al. Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant. Biol Blood Marrow Transplant 2009; 15: 589-596.
35. Dauber K, Odendahl M, Becker D, Tonn T, Bonig H. 7-AAD systematically overestimates viability of CD34 cells in previously frozen samples. Vox Sanguinis 2010; 97: 478.
36. Kao GS, Kim HT, Daley H, Ritz J, Burger SR, Kelley L et al. Validation of short-term handling and storage conditions for marrow and peripheral blood stem cell products. Transfusion 2011; 51: 137-147.
37. Fry LJ, Giner SQ, Gomez SG, Green M, Anderson S, Horder J et al. Avoiding room temperature storage and delayed cryopreservation provide better postthaw potency in hematopoietic progenitor cell grafts. Transfusion 2013; 53: 1834-1842.
38. Antonenas V, Garvin F, Webb M, Sartor M, Bradstock KF, Gottlieb D. Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport. Cytotherapy 2006; 8: 158-165
39. Lasky LC, McCullough J, Zanjani ED. Liquid storage of unseparated human bone marrow. Evaluation of hematopoietic progenitors by clonal assay. Transfusion 1986; 26: 331-334.
40. Schepers KG, Davis JM, Rowley SD. Incidence of bacterial contamination of bone marrow grafts. Prog Clin Biol Res 1992; 377: 379-384.
41. Attarian H, Bensinger WI, Buckner CD, McDonald DL, Rowley SD. Microbial contamination of peripheral blood stem cell collections. Bone Marrow Transplant 1996; 17: 699-702.
42. Klein MA, Kadidlo D, McCullough J, McKenna DH, Burns LJ. Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae. Biol. Blood Marrow Transplant 2006; 12: 1142-1149.
43. Padley DJ, Dietz AB, Gastineau DA. Sterility testing of hematopoietic progenitor cell products: a single-institution series of culture-positive rates and successful infusion of culture-positive products. Transfusion 2007; 47: 636-643.
44. Brecher ME, Holland PV, Pineda AA, Tegtmeier GE, Yomtovian R. Growth of bacteria in inoculated platelets: implications for bacteria detection and the extension of platelet storage. Transfusion 2000; 40: 1308-1312.
45. Hillyer CD, Josephson CD, Blajchman MA, Vostal JG, Epstein JS, Goodman JL. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. Hematology Am Soc Hematol Educ Program 2003; 2003: 575-589.
46. Montag T, Nicol S, Schurig U, Heiden M, Huber H, Sanzenbacher R et al. Microbial safety of cell based medicinal products-what can we learn from cellular blood components? Clin Chem Lab Med 2008; 46: 963-965.
47. Leeming JP, Holland KT, Cunliffe WJ. The microbial ecology of pilosebaceous units isolated from human skin. J Gen Microbiol 1984; 130: 803-807.
48. Wagner SJ, Robinette D. Evaluation of an automated microbiologic blood culture device for detection of bacteria in platelet components. Transfusion 1998; 38: 674-679.
49. Brecher ME, Means N, Jere CS, Heath D, Rothenberg S, Stutzman LC. Evaluation of an automated culture system for detecting bacterial contamination of platelets: an analysis with 15 contaminating organisms. Transfusion 2001; 41: 477-482.
50. Brecher ME, Hay SN, Rose AD, Rothenberg SJ. Evaluation of BacT/ALERT plastic culture bottles for use in testing pooled whole blood-derived leukoreduced platelet-rich plasma platelets with a single contaminated unit. Transfusion 2005; 45: 1512-1517.
51. Adams MR, Moss MO. Food Microbiology. 3rd ed. RSC Publishing: Cambridge, UK, 2008.
52. Dworkin M, Falkow S, Rosenberg E, Schleifer K, Stackebrandt E (eds). The Prokaryotes. Springer: New York, NY, 2006.
53. Paul-Ehrlich-Institut. Stellungnahme des Paul-Ehrlich-Instituts zur mikro-biologischen Kontrolle von hämatopoietischen Stammzellprä paraten; 2012. Available from: http://www.pei.de/SharedDocs/Downloads/blut/ stammzellen-genehmigung-21a-amg/pei-stellungnahme-mikrobiologische-kontrolle- stammzellen.pdf;jsessionid = 373BB1831632E9664A2896E6724B2F19.1- cid354?-blob = publicationFile&v =3 (accessed 9 June 2013).
54. Mohr H, Bayer A, Gravemann U, Müller TH. Elimination and multiplication of bacteria during preparation and storage of buffy coat-derived platelet concentrates. Transfusion 2006; 46: 949-955.
55. Kuehnert MJ, Roth VR, Haley NR, Gregory KR, Elder KV, Schreiber GB et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001; 41: 1493-1499.
56. Melly MA, Thomison JB, Rogers DE. Fate of staphylococci within human leukocytes. J Exp Med 1960; 112: 1121-1130.
57. Vries R de, Faber J (eds.) Hemovigilance: An Effective Tool for Improving Transfusion Safety. 1st ed. Wiley & Sons: Chichester, UK, 2012.
58. Högman CF, Gong J, Eriksson L, Hambraeus A, Johansson CS. White cells protect donor blood against bacterial contamination. Transfusion 1991; 31: 620-626.
59. Sanz C, Pereira A, Vila J, Faundez AI, Gomez J, Ordinas A. Growth of bacteria in platelet concentrates obtained from whole blood stored for 16h at 22 degrees C before component preparation. Transfusion 1997; 37: 251-254.
60. Cohen A, Tepperberg M, Waters-Pick B, Coniglio D, Perfect J, Peters WP et al. The significance of microbial cultures of the hematopoietic support for patients receiving high-dose chemotherapy. J Hematother 1996; 5: 289-294.
61. Kelley JM, Onderdonk AB, Kao G. Bacillus cereus septicemia attributed to a matched unrelated bone marrow transplant. Transfusion 2013; 53: 394-397.
62. Medeiros CRde, Faoro LN, Friedrich ML, Pereira N, Cunha CA, Pasquini R. Unrelated bone marrow as a source of Bacillus cereus causing septic shock. Bone Marrow Transplant 2000; 26: 1259-1260.
63. Nifong TP, Ehmann WC, Mierski JA, Domen RE, Rybka WB. Favorable outcome after infusion of coagulase-negative staphylococci-contaminated peripheral blood hematopoietic cells for autologous transplantation. Arch Pathol Lab Med 2003; 127: e19-e21.
64. Barrett BB, Andersen JW, Anderson KC. Strategies for the avoidance of bacterial contamination of blood components. Transfusion 1993; 33: 228-233.
65. Buchholz DH, Young VM, Friedman NR, Reilly JA, Mardiney MR. Detection and quantitation of bacteria in platelet products stored at ambient temperature. Transfusion 1973; 13: 268-275.
66. Robert Koch-Institut (RKI). Reduktion des Septikämierisikos bei der Anwendung von Thrombozytenkonzentraten; 2008. Available from: URL:http://edoc.rki.de/documents/rki-ab/re8QBEDfM7uFI/PDF/29wmzUschTXdbM.pdf. (last accessed 9-06-2013).